Does Rallies show Form 4 insider transactions for GEHC?

Yes. Rallies tracks GEHC insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is GEHC research on Rallies investment advice?

No. Rallies provides research, data, and educational context for GEHC. It does not provide personalized investment advice.

GEHC (GE HealthCare Technologies Inc. Common Stock) Stock Analysis - Insider Trades

GE HealthCare Technologies Inc. Common Stock (GEHC) is a publicly traded Healthcare sector company. As of May 20, 2026, GEHC trades at $64.01 with a market cap of $27.98B and a P/E ratio of 15.35. GEHC moved +4.35% today. Year to date, GEHC is -24.44%; over the trailing twelve months it is -10.56%. Its 52-week range spans $57.65 to $94.80. Analyst consensus is buy with an average price target of $82.36. Rallies surfaces GEHC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading GEHC stock inside the company?

Recent GEHC insider activity includes Hochman Rodney F bought 1.62K, Yang Watkin Phoebe L. bought 1.00K, CULP H LAWRENCE JR bought 80.81K, Stromberg William J bought 1.00K, and SACCARO JAMES bought 3.31K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

GEHC Key Metrics

Key financial metrics for GEHC
Metric	Value
Price	$64.01
Market Cap	$27.98B
P/E Ratio	15.35
EPS	$4.18
Dividend Yield	0.04%
52-Week High	$94.80
52-Week Low	$57.65
Volume	6.48M
Avg Volume	0
Revenue (TTM)	$20.98B
Net Income	$1.98B
Gross Margin	39.15%

Recent GEHC Insider Trades

Hochman Rodney F bought 1.62K (~$100.36K) on May 12, 2026.
Yang Watkin Phoebe L. bought 1.00K (~$63.01K) on May 8, 2026.
CULP H LAWRENCE JR bought 80.81K (~$5.00M) on May 6, 2026.
Stromberg William J bought 1.00K (~$61.69K) on May 6, 2026.
SACCARO JAMES bought 3.31K (~$200.59K) on May 1, 2026.

Latest GEHC News

Ventripoint Files AI Cardiac Imaging to NMPA, Exhibits at AEPC Congress — May 19, 2026
GE HealthCare Cuts 2026 EPS Guidance to $4.80-$5.00, Shares Plunge 13% — May 1, 2026
GE HealthCare plunges as Q1 EPS miss triggers 2026 guidance cut on cost pressures — Apr 30, 2026
GE HealthCare Lowers 2026 EPS to $4.80–$5.00 After Q1 EPS Miss — Apr 29, 2026
GE HealthCare Shares Fall 6% After Q1 EPS Miss, Full-Year EPS Cut to $4.80–$5.00 — Apr 29, 2026

GEHC Analyst Consensus

12 analysts cover GEHC: 0 strong buy, 8 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $82.36.

Common questions about GEHC

Who is trading GEHC stock inside the company?: Recent GEHC insider activity includes Hochman Rodney F bought 1.62K, Yang Watkin Phoebe L. bought 1.00K, CULP H LAWRENCE JR bought 80.81K, Stromberg William J bought 1.00K, and SACCARO JAMES bought 3.31K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for GEHC?: Yes. Rallies tracks GEHC insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is GEHC research on Rallies investment advice?: No. Rallies provides research, data, and educational context for GEHC. It does not provide personalized investment advice.